NANadire Işık Erol Algül

Nadire Işık Erol Algül

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadire Işık Erol Algül has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum apelin levels in established pulmonary arterial hypertension: A cross-sectional case–control study

    by Mehmet Taha Özkan, Hilal Erken, Alperen Taş, Çağatay Tunca, Ayşenur Özkaya İbiş, Nadire Işık Erol Algül, Gürkan İş, Saadet Demirtaş İnci

  • Prognostic Value of the CALLY Index in Predicting Contrast-Associated Acute Kidney Injury in Patients With Acute Coronary Syndrome

    by Nadire Işık Erol Algül, Muhammed Erzurum, Mehmet ali Felekoğlu, Mehmet Emre Özerdem, Nail Burak Özbeyaz, Engin Algül

    Contrast-associated acute kidney injury (CA-AKI) is a serious complication associated with increased morbidity and mortality in patients with acute coronary syndrome (ACS) undergoing coronary angiography. The C-reactive protein-albumin-lymphocyte (CALLY) index is a novel biomarker reflecting inflammatory and nutritional status. This retrospective study evaluated the prognostic value of the CALLY index calculated at hospital admission for predicting CA-AKI in 1516 patients with ACS. CA-AKI developed in 267 patients (17.6%). Patients who developed CA-AKI had significantly lower CALLY index values (0.35 ± 0.16 vs 0.84 ± 0.30; P < .001). In separate multivariable logistic regression analyses adjusted for baseline clinical and procedural confounders, the CALLY index emerged as an independent predictor of CA-AKI (Odds ratio [OR] 0.592 per 0.1-unit increase; 95% CI 0.525-0.668; P < .001). Receiver operating characteristic curve analysis demonstrated good discriminatory capacity for the CALLY index (Area Under the Curve [AUC] = 0.822), significantly outperforming conventional clinical scores and other inflammatory indices (DeLong test P < .001). Furthermore, adding the CALLY index to the Mehran risk score significantly improved reclassification metrics (Net Reclassification Improvement [NRI] = 14.2%, Integrated Discrimination Improvement [IDI] = 0.048; P < .001). The CALLY index serves as a simple, practical, and effective score for early CA-AKI risk stratification in ACS.


  • Effect of SGLT2 Inhibitors on Atrial Electromechanical Delay in Patients with Type 2 Diabetes

    by Muhammed Erzurum, Mehmet Ali Felekoğlu, Nadire Isık Erol Algül, Alperen Taş, Nail Burak Özbeyaz, Engin Algül, Faruk Aydinyilmaz, Kamuran Kalkan, Tolga Han Efe

    Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been associated with lower atrial fibrillation (AF) incidence in diabetes mellitus (DM). Atrial electromechanical delay (AEMD) is an electrophysiological marker related to AF development. This study evaluated AEMD changes in type 2 DM patients treated with an SGLT2 inhibitor (dapagliflozin or empagliflozin). Baseline and 4-month follow-up data of 50 patients with type 2 diabetes who initiated SGLT2 inhibitor therapy were retrospectively obtained from medical records and analyzed. AEMD was measured using echocardiography and tissue Doppler. Inter-AEMD and intra-AEMD intervals were calculated. Left atrial volume (LAVOL) significantly decreased (45.23 ± 9.27 vs 42.21 ± 9.16; P < .001), while left intra-AEMD (19.58 ± 7.53 vs 16.76 ± 7.53; P <.001), right intra-AEMD (14.42 ± 5.81 vs 12.46 ± 8.05; P = .016), and inter-AEMD (34 ± 9.41 vs 29.22 ± 9.44; P < .001) were significantly reduced. Inter-AEMD change correlated with LAVOL, E/E′ ratio, body mass index, and mean blood pressure changes (all P <.05). In diabetic patients treated with SGLT2 inhibitors, AEMD reduction was observed after 4 months, with favorable metabolic and hemodynamic effects. These findings suggest that SGLT2 inhibitors may protect against AF by improving atrial electromechanical function.


  • Prognostic Value of the Endothelial Activation and Stress Index in Patients with Non–ST-Segment Elevation Myocardial Infarction

    by Muhammed Erzurum, Veysel Ozan Tanık, Alperen Taş, Mehmet Taha Özkan, Tuğba Kapanşahin, Mehmet Ali Felekoğlu, Nadire Işık Erol Algül, Faruk Aydınyılmaz, İlKin Guliyev, Kamuran Kalkan

    Background: Early risk stratification is essential in patients with non–ST-segment elevation myocardial infarction (NSTEMI). The Endothelial Activation and Stress Index (EASIX) reflects endothelial dysfunction and systemic stress; however, its prognostic value in NSTEMI remains unclear. This study aimed to investigate the association between EASIX and in-hospital mortality in patients with NSTEMI. Methods: This retrospective, single-center observational study included 1001 consecutive NSTEMI patients hospitalized between January 2015 and August 2025. Endothelial Activation and Stress Index was calculated at admission using lactate dehydrogenase, creatinine, and platelet count. Univariable and multivariable logistic regression analyses were performed to identify independent predictors of in-hospital mortality. Discriminative performance was assessed using receiver operating characteristic analysis and Kaplan–Meier survival analysis. Results: In-hospital mortality occurred in 41 patients (4.1%). Non-survivors had significantly higher EASIX values than survivors (median 1.76 vs. 0.94, P < .001). In multivariable analysis, EASIX (OR 1.66, 95% CI 1.24-2.23; P = .001), GRACE score (OR 1.04, 95% CI 1.03-1.06; P < .001), and revascularization (OR 0.37, 95% CI 0.15-0.55; P = .003) remained independent predictors of in-hospital mortality. EASIX demonstrated good discriminative ability (AUC 0.770), and higher levels were associated with worse survival. Conclusion: Endothelial Activation and Stress Index is an independent and practical predictor of in-hospital mortality in NSTEMI and may aid early risk stratification using routine laboratory data.

  • Open Access

    Naples prognostic score predicts acute kidney injury in acute coronary syndrome patients undergoing primary percutaneous coronary intervention

    by Engin Algül, Nail Burak Özbeyaz, Nadire Işık Erol Algül

    Aims: Acute kidney injury (AKI) is a frequent complication in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). The Naples prognostic score (NPS), which integrates inflammatory and nutritional markers, may improve identification of patients at higher risk for AKI. This study aimed to evaluate the predictive value of NPS for AKI in ACS patients undergoing PCI. Methods: We retrospectively analyzed 1360 ACS patients treated with PCI. AKI was defined as an increase in serum creatinine ≥0.5 mg/dl or ≥25% from baseline within 48–72 hours after the procedure. NPS was calculated using serum albumin, total cholesterol, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR). Patients were categorized into low-risk (NPS 0–2) and high-risk (NPS 3–4) groups. Logistic regression and ROC analysis were performed. Results: AKI occurred in 221 patients (16.3%). Patients with AKI were older and had higher rates of diabetes, heart failure (HF), and LAD involvement. In multivariate analysis, high NPS was independently associated with AKI (OR=4.127, 95% CI: 4.008–4.460, p